Commission Regulation (EC) No 1943/1999 of 10 September 1999 amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance)
Date: 1999-09-10
Institutions: European Commission
Subjects: animal product, food inspection, public health, veterinary drug, veterinary legislation, waste

11. 9. 1999

EN

Official Journal of the European Communities

L 241/9

COMMISSION REGULATION (EC) No 1943/1999

of 10 September 1999

amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community
procedure for the establishment of maximum residue limits of veterinary medicinal products in
foodstuffs of animal origin

(Text with EEA relevance)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

honey bees, maximum residue limits must also be estab-
lished for eggs, milk or honey;

Having regard to the Treaty establishing the European
Community,

(6) Whereas eprinomectin should be inserted into Annex I

to Regulation (EEC) No 2377/90;

Having regard to Council Regulation (EEC) No 2377/90 of 26
June 1990 laying down a Community procedure for the estab-
lishment of maximum residue limits of veterinary medicinal
products in foodstuffs of animal origin (1), as last amended by
Commission Regulation (EC) No 1942/1999 (2), and in par-
ticular Articles 6, 7 and 8 thereof,

(1) Whereas,

in accordance with Regulation (EEC) No
2377/90, maximum residue limits must be established
progressively for all pharmacologically active substances
which are used within the Community in veterinary
medicinal products intended for administration to food-
producing animals;

(2) Whereas maximum residue limits should be established
only after the examination within the Committee for
in-
Veterinary Medicinal Products of all
formation concerning the safety of
the
substance concerned for the consumer of foodstuffs of
animal origin and the impact of residues on the indus-
trial processing of foodstuffs;

the relevant
residues of

(3) Whereas,

in establishing maximum residue limits for
residues of veterinary medicinal products in foodstuffs
of animal origin, it is necessary to specify the animal
species in which residues may be present, the levels
which may be present in each of the relevant meat
tissues obtained from the treated animal (target tissue)
and the nature of the residue which is relevant for the
monitoring of residues (marker residue);

(4) Whereas, for the control of residues, as provided for in
appropriate Community legislation, maximum residue
limits should usually be established for the target tissues
of
the liver and
kidney are frequently removed from carcasses moving in
international trade, and maximum residue limits should
therefore also always be established for muscle or fat
tissues;

liver or kidney; whereas, however,

(7) Whereas cefoperazone and atropine should be inserted
into Annex II to Regulation (EEC) No 2377/90;

(8) Whereas,

in order

the completion of
to allow for
scientific studies, cefoperazone should be inserted into
Annex III to Regulation (EEC) No 2377/90;

(9) Whereas,

in order

the completion of
to allow for
scientific studies, the duration of the validity of the
provisional maximum residue limits previously defined
in Annex III of Regulation (EEC) No 2377/90 should be
extended for clavulanic acid;

(10) Whereas a period of 60 days should be allowed before
the entry into force of this Regulation in order to allow
Member States to make any adjustment which may be
necessary to the authorisations to place the veterinary
medicinal products concerned on the market which have
been granted in accordance with Council Directive
81/851/EEC (3),
by Directive
93/40/EEC (4) to take account of the provisions of this
Regulation;

amended

last

as

(11) Whereas the measures provided for in this Regulation
are in accordance with the opinion of the Standing
Committee on Veterinary Medicinal Products,

HAS ADOPTED THE FOLLOWING REGULATION:

Article 1

Annexes I,
hereby amended as set out in the Annex hereto.

II and III of Regulation (EEC) No 2377/90 are

Article 2

(5) Whereas, in the case of veterinary medicinal products
lactating animals or

intended for use in laying birds,

into force on the 60th day
This Regulation shall enter
following its publication in the Official Journal of the European
Communities.

(1) OJ L 224, 18.8.1990, p. 1.
(2) See page 4 of this Official Journal.

(3) OJ L 317, 6.11.1981, p. 1.
(4) OJ L 214, 24.8.1993, p. 31.

L 241/10

EN

Official Journal of the European Communities

11. 9. 1999

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 10 September 1999.

For the Commission

Karel VAN MIERT

Member of the Commission

11. 9. 1999

EN

Official Journal of the European Communities

L 241/11

s
e
u
s
s
i
t

l
l
a

r
o
f

d
n
a

y
l
n
o

s
w
o
c

g
n
i
t
a
t
c
a
l

n

i

e
s
u

y
r
a
m
m
a
m
a
r
t
n

i

r
o
F

’

k
l
i

m

t
p
e
c
x
e

s
e
i
c
e
p
s

g
n
i
c
u
d
o
r
p

d
o
o
f

l
l

A

e
n
i
v
o
B

e
n
o
z
a
r
e
p
o
f
e
C

i

e
n
p
o
r
t
A

‘

s
n
o
i
s
i
v
o
r
p

r
e
h
t
O

s
e
i
c
e
p
s

l
a
m
n
A

i

)
s
(
e
c
n
a
t
s
b
u
s

e
v
i
t
c
a

l

y
l
l
a
c
i
g
o
o
c
a
m
r
a
h
P

e
l
c
s
u
M

g
k
/
g
µ

0
5

t
a
F

g
k
/
g
µ

0
5
2

r
e
v
i
L

g
k
/
g
µ

0
0
5
1

y
e
n
d
K

i

g
k
/
g
µ

0
0
3

’

k
l
i

M

g
k
/
g
µ

0
2

e
n
i
v
o
B

a
1
B

n
i
t
c
e
m
o
n
i
r
p
E

n
i
t
c
e
m
o
n
i
r
p
E

‘

:
s
w
o

l
l

o
f

s
a

d
e
d
n
e
m
a

s
i

0
9
/
7
7
3
2

o
N

)

C
E
E
(

n
o
i
t
a
l
u
g
e
R

o
t

I
I

x
e
n
n
A

s
d
n
u
o
p
m
o
c

c
i
n
a
g
r
O

.

2

s
n
o
i
s
i
v
o
r
p

r
e
h
t
O

s
e
u
s
s
i
t

t
e
g
r
a
T

s
L
R
M

s
e
i
c
e
p
s

l
a
m
n
A

i

e
u
d
i
s
e
r

r
e
k
r
a
M

e
v
i
t
c
a

l

y
l
l
a
c
i
g
o
o
c
a
m
r
a
h
P

e
c
n
a
t
s
b
u
s

s
n
i
t
c
e
m
r
e
v
A

.

.

1
3
2

.

X
E
N
N
A

:
s
w
o

l
l

o
f

s
a

d
e
d
n
e
m
a

s
i

0
9
/
7
7
3
2

o
N

)

C
E
E
(

n
o
i
t
a
l
u
g
e
R

o
t

I

x
e
n
n
A

s
e
t
i
s
a
r
a
p
o
t
c
e

d
n
a

-
o
d
n
e

t
s
n
i
a
g
a

g
n
i
t
c
a

s
t
n
e
g
A

.

3
2

.

s
t
n
e
g
a

c
i
t
i
s
a
r
a
p
i
t
n
A

.

2

L 241/12

EN

Official Journal of the European Communities

11. 9. 1999

e
l
c
s
u
M

g
k
/
g
µ

0
0
2

r
e
v
i
L

g
k
/
g
µ

0
0
2

t
a
F

g
k
/
g
µ

0
0
2

y
e
n
d
K

i

g
k
/
g
µ

0
0
2

e
n
i
c
r
o
p

,
e
n
i
v
o

,
e
n
i
v
o
B

’

1
0
0
2

y
l
u
J

1

n
o

e
r
i
p
x
e

s
L
R
M

l
a
n
o
i
s
i
v
o
r
P

k
l
i

M

g
k
/
g
µ

0
0
2

e
n
i
v
o

,
e
n
i
v
o
B

d
i
c
a

c
i
n
a
l
u
v
a
l
C

d
i
c
a

c
i
n
a
l
u
v
a
l
C

‘

s
n
o
i
s
i
v
o
r
p

r
e
h
t
O

s
e
u
s
s
i
t

t
e
g
r
a
T

s
L
R
M

s
e
i
c
e
p
s

l
a
m
n
A

i

e
u
d
i
s
e
r

r
e
k
r
a
M

e
v
i
t
c
a

l

y
l
l
a
c
i
g
o
o
c
a
m
r
a
h
P

e
c
n
a
t
s
b
u
s

s
r
o
t
i
b
h
n
I

i

e
s
a
m
a
t
c
a
l
-
a
t
e
B

.

’

1
0
0
2

y
r
a
u
n
a
J

1

n
o

e
r
i
p
x
e

s
L
R
M

l
a
n
o
i
s
i
v
o
r
P

k
l
i

M

g
k
/
g
µ

0
5

e
n
i
v
o
B

e
n
o
z
a
r
e
p
o
f
e
C

e
n
o
z
a
r
e
p
o
f
e
C

‘

s
n
o
i
s
i
v
o
r
p

r
e
h
t
O

s
e
u
s
s
i
t

t
e
g
r
a
T

s
L
R
M

s
e
i
c
e
p
s

l
a
m
n
A

i

e
u
d
i
s
e
r

r
e
k
r
a
M

e
v
i
t
c
a

l

y
l
l
a
c
i
g
o
o
c
a
m
r
a
h
P

e
c
n
a
t
s
b
u
s

s
n
i
r
o
p
s
o
l
a
h
p
e
C

.

.

1
2
1

.

.

4
2
1

.

:
s
w
o

l
l

o
f

s
a

d
e
d
n
e
m
a

s
i

0
9
/
7
7
3
2

o
N

)

C
E
E
(

n
o
i
t
a
l
u
g
e
R

o
t

I
I
I

x
e
n
n
A

s
t
n
e
g
a

s
u
o
i
t
c
e
f
n
i
-
i
t
n
A

.

1

i

s
c
i
t
o
b
i
t
n
A

.

2
1

.